Menu

Vir Biotechnology, Inc. VIR

Full chart Compare
Set alert

Price alert · VIR

All alert types
12.21 USD +1.19 (+10.80%)

At closeNov 6, 2026, 7:45 PM EST

12.32 +0.11 +0.91%

After hours · Nov 6, 7:45 PM ET

11.30 Day range 12.45
5.12 52-week range 12.21
YTD
+102.49%
1 year
+138.48%

Revenue & Expenses

Other Income → Expenses: $41.56MOther Operating Income → Expenses: $182.00KExpenses → Selling, General & Admin: $92.07MExpenses → Research & Development: $455.97MExpenses → Income Tax: $217.00KGross Profit → Expenses: $68.53MRevenue → Gross Profit: $68.53MRevenue → Cost of Revenue: $26.00KNet Loss → Expenses: $437.99MOther Income$41.56MOther Operating Income$182.00KGross Profit$68.53MNet Loss$437.99MCost of Revenue$26.00KExpenses$548.26MSelling, General & Admin$92.07MResearch & Development$455.97MIncome Tax$217.00KRevenue$68.56M

Latest period ending Dec 31, 2025 · select a line to chart its full history

VIR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
68.56M74.20M86.18M1.62B1.10B
68.53M73.36M83.42M1.47B1.03B
-479.33M-587.16M-684.30M833.07M420.75M
-437.99M-521.96M-615.06M515.84M528.58M
-3.16-3.83-4.593.833.96
VIR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
234.11M312.33M254.84M861.31M356.41M
1.00B1.40B1.92B2.80B1.95B
237.55M248.43M328.82M724.13M522.42M
89.05M90.14M111.67M123.84M133.56M
765.28M1.15B1.59B2.08B1.43B
VIR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-391.78M-446.35M-778.78M1.66B-47.59M
310.37M499.37M164.63M-1.19B-140.81M
3.79M4.39M7.48M34.76M100.33M
-4.58M-3.93M-21.57M-68.01M-21.82M
-77.63M57.40M-606.68M504.55M-88.07M